DAX23.739 +0,9%ESt505.500 +1,0%Top 10 Crypto15,32 +0,4%Dow46.247 +0,7%Nas22.484 +0,4%Bitcoin93.664 -0,1%Euro1,1704 ±0,0%Öl69,75 +0,2%Gold3.763 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Lufthansa 823212 NVIDIA 918422 DroneShield A2DMAA Novo Nordisk A3EU6F Tesla A1CX3T RENK RENK73 Allianz 840400 HENSOLDT HAG000 Deutsche Telekom 555750 Amazon 906866 SAP 716460 BASF BASF11 Volkswagen (VW) vz. 766403 Siemens Energy ENER6Y
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach US-Inflationsdaten: DAX geht höher ins Wochenende -- US-Börsen fest -- Höhere Trump-Zölle auf Arzneimittel & Co. -- Gerresheimer, Intel, Plug Power, Siemens, Rheinmetall, D-Wave, Oracle im Fokus
Top News
Aktien von BMW, VW, Porsche & Co. im Blick: Kfz-Steuerbefreiung für neue E-Autos steht zur Diskussion Aktien von BMW, VW, Porsche & Co. im Blick: Kfz-Steuerbefreiung für neue E-Autos steht zur Diskussion
KW 39: So haben Bitcoin, Ether & Co. in der vergangenen Woche performt KW 39: So haben Bitcoin, Ether & Co. in der vergangenen Woche performt
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Novavax Aktie

Kaufen
Verkaufen
Novavax Aktien-Sparplan
7,32 EUR +0,17 EUR +2,42 %
BMN
8,54 USD -0,01 USD -0,06 %
nachbörslich
BTT
Novavax jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.1,19 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PKMZ

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS6700024010

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolNVAX

Novavax Aktien News

DatumMeistgelesen
PR NewswireNovavax's Updated COVID-19 Vaccine Now Authorized in Canada
PR NewswireNovavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
PR NewswireNovavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
PR NewswireNovavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
PR NewswireNovavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
PR NewswireNovavax to Participate in Jefferies London Healthcare Conference
PR NewswireNovavax Reports Third Quarter 2023 Financial Results and Operational Highlights
PR NewswireNovavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023
PR NewswireNovavax's Updated COVID-19 Vaccine Now Approved in the EU
PR NewswireNovavax's Updated COVID-19 Vaccine Now Approved in the EU
PR NewswireNovavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU
PR NewswireNovavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU
PR NewswireNovavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United Kingdom
PR NewswireNovavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
PR NewswireNovavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
PR NewswireNovavax COVID-19 Vaccine Doses Available at Major Retail Pharmacies Across the U.S.
PR NewswireNovavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023
PR NewswireNovavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023
PR NewswireNovavax Launches Choose to Protect™ Campaign to Educate Public About Importance of Updated COVID Vaccination this Fall
PR NewswireNovavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
PR NewswireNovavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
PR NewswireNovavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
PR NewswireNovavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
PR NewswireNovavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR NewswireNovavax to Participate in Upcoming September Conferences
PR NewswireNovavax's Updated Protein-based XBB COVID Vaccine Induced Neutralizing Responses Against Emerging Subvariants, Including EG.5.1 and XBB.1.16.6
PR NewswireNovavax's Updated Protein-based XBB COVID Vaccine Induced Neutralizing Responses Against Emerging Subvariants, Including EG.5.1 and XBB.1.16.6
PR NewswireNovavax Reports Second Quarter 2023 Financial Results and Operational Highlights
PR NewswireNovavax to Host Conference Call to Discuss Second Quarter 2023 Financial Results and Operational Highlights on August 8, 2023
PR NewswireNovavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall
PR NewswireNovavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall
PR NewswireNovavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall
PR NewswireNovavax Announces Adjournment of 2023 Annual Meeting of Stockholders to July 11, 2023
PR NewswireNovavax Announces Agreement with Bill & Melinda Gates Medical Research Institute to Include Matrix-M™ Adjuvant as Potential Component in Vaccine Research
PR NewswireNovavax Announces Agreement with Bill & Melinda Gates Medical Research Institute to Include Matrix-M™ Adjuvant as Potential Component in Vaccine Research
PR NewswireNovavax to Participate in the Jefferies Global Healthcare Conference
PR NewswireNovavax's Nuvaxovid™ Receives Positive CHMP Opinion for Full Marketing Authorization for the Prevention of COVID in the EU
PR NewswireNovavax's Nuvaxovid™ Receives Positive CHMP Opinion for Full Marketing Authorization for the Prevention of COVID in the EU
PR NewswireAccess to Novavax's COVID Vaccine Grows with Extended Interim Authorization for Adolescents in Singapore
PR NewswireAccess to Novavax's COVID Vaccine Grows with Extended Interim Authorization for Adolescents in Singapore

Novavax News

Novavax News: auf dieser Seite finden Sie alle Novavax News und Nachrichten zur Novavax Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novavax News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novavax News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.